Composition
- Active ingredients
- TRIFLUOPERAZINE HYDROCHLORIDE EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TRIFLUOPERAZINE HYDROCHLORIDE EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA011552-005 · Discontinued
- TRIFLUOPERAZINE HYDROCHLORIDE EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA011552-003 · Discontinued
- TRIFLUOPERAZINE HYDROCHLORIDE EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA011552-001 · Discontinued
- TRIFLUOPERAZINE HYDROCHLORIDE EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · ConcentrateThis page
- TRIFLUOPERAZINE HYDROCHLORIDE EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA011552-004 · Discontinued
- TRIFLUOPERAZINE HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA011552-002 · Discontinued
Official product information
At a glance
- Brand name
- Stelazine
- Active substance
- trifluoperazine hydrochloride
- Route
- Oral
- Dosage form
- Concentrate
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 16 Apr 1959
- Application
- NDA011552-006